User profiles for W. Seeger
Werner SeegerProfessor, Justus Liebig University Giessen; MPI-HLR; CPI; UGMLC; DZL; ILH Verified email at ugmlc.de Cited by 87783 |
Clinical classification of pulmonary hypertension
In 1998, during the Second World Symposium on Pulmonary Hypertension (PH) held in
Evian, France, a clinical classification of PH was proposed. The aim of the Evian classification …
Evian, France, a clinical classification of PH was proposed. The aim of the Evian classification …
Updated treatment algorithm of pulmonary arterial hypertension
The demands on a pulmonary arterial hypertension (PAH) treatment algorithm are multiple
and in some ways conflicting. The treatment algorithm usually includes different types of …
and in some ways conflicting. The treatment algorithm usually includes different types of …
Pulmonary hypertension due to left heart diseases
… Seeger has received speaker fees from Pfizer and Bayer HealthCare; and is a consultant
for Bayer Pharma AG. All other authors have reported that they have no relationships relevant …
for Bayer Pharma AG. All other authors have reported that they have no relationships relevant …
[HTML][HTML] Inhaled iloprost for severe pulmonary hypertension
…, H Siedentop, W Seeger - … England Journal of …, 2002 - Mass Medical Soc
Background Uncontrolled studies suggested that aerosolized iloprost, a stable analogue of
prostacyclin, causes selective pulmonary vasodilatation and improves hemodynamics and …
prostacyclin, causes selective pulmonary vasodilatation and improves hemodynamics and …
[HTML][HTML] Reversal of experimental pulmonary hypertension by PDGF inhibition
Progression of pulmonary hypertension is associated with increased proliferation and migration
of pulmonary vascular smooth muscle cells. PDGF is a potent mitogen and involved in …
of pulmonary vascular smooth muscle cells. PDGF is a potent mitogen and involved in …
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
…, N Weissmann, A Gunther, D Walmrath, W Seeger… - The Lancet, 2002 - thelancet.com
… Werner Seeger … Seeger W … HA Ghofrani, H Olschewski, W Seeger, and F
Grimminger participated in analysis and interpretation of data, and revision of the report. …
Grimminger participated in analysis and interpretation of data, and revision of the report. …
Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy
…, H Olschewski, K Mayer, W Seeger… - American journal of …, 2000 - atsjournals.org
Obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity and
mortality. Free oxygen radicals have been implicated in the pathogenesis of cardiovascular …
mortality. Free oxygen radicals have been implicated in the pathogenesis of cardiovascular …
Pulmonary hypertension in chronic lung diseases
W Seeger, Y Adir, JA Barberà, H Champion… - Journal of the American …, 2013 - jacc.org
… Seeger has received speaker fees from Pfizer and Bayer HealthCare; and consultant
fees from Bayer Pharma AG. Dr. Barberà has received honoraria and consultancy fees from …
fees from Bayer Pharma AG. Dr. Barberà has received honoraria and consultancy fees from …
Real-time quantitative RT–PCR after laser-assisted cell picking
L Fink, W Seeger, L Ermert, J Hänze, U Stahl… - Nature medicine, 1998 - nature.com
NEW TECHNOLOGY one11. However, affecting factors will vary only negligibly among single
samples so that K is assumed to be equal and thus does not influence the comparison of …
samples so that K is assumed to be equal and thus does not influence the comparison of …
Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension
…, RT Schermuly, N Weissmann, W Seeger… - Annals of internal …, 2002 - acpjournals.org
Background: Inhalation of the stable prostacyclin analogue iloprost is being studied for
treatment of pulmonary hypertension. The selective phosphodiesterase-5 inhibitor sildenafil has …
treatment of pulmonary hypertension. The selective phosphodiesterase-5 inhibitor sildenafil has …